Showing results (51-60 of 98) with videos related to
Sort By:
Pageof 10
Diagnostics (Basel, Switzerland)|February 24, 2024
A Machine Learning Predictive Model of Bloodstream Infection in Hospitalized PatientsRita Murri, Giulia De Angelis, Laura Antenucci, et al.Medicina (Kaunas, Lithuania)|July 2, 2021
Post-Prescription Audit Plus Beta-D-Glucan Assessment Decrease Echinocandin Use in People with Suspected Invasive CandidiasisRita Murri, Sara Lardo, Alessio De Luca, et al.Journal of Personalized Medicine|June 28, 2023
Association between Older Age and Psychiatric Symptoms in a Population of Hospitalized Patients with COVID-19Maria Camilla Cipriani, Cristina Pais, Vezio Savoia, et al.Journal of Clinical Medicine|March 14, 2026
Prevention and Treatment of Surgical Site Infections in Orthopaedic Surgery: An Italian Delphi Consensus on Risk Stratification and Wound Irrigation StrategiesPier Francesco Indelli, Massimiliano De Paolis, Arcangelo Russo, et al.The Journal of Antimicrobial Chemotherapy|July 14, 2026
Ceftaroline and ceftobiprole monotherapy for the treatment of Staphylococcus aureus infections: a systematic review and Bayesian meta-analysisEmanuele Rando, Eugenia Magrini, Flavio Sangiorgi, et al.Infectious Disease Reports|July 27, 2022
Neurocysticercosis in Low- and Middle-Income Countries, a Diagnostic Challenge from Oyam District, UgandaFrancesco Vladimiro Segala, Elda De Vita, James Amone, et al.Annals of Internal Medicine|November 5, 2019
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort StudyGianluca Ianiro, Rita Murri, Giusi Desirè Sciumè, et al.Journal of Internal Medicine|November 13, 2024
Incidence and predictors of clinical failure after early treatment for mild-to-moderate COVID-19 in high-risk individuals: A multicentric cohort studyIlaria Mastrorosa, Alessandro Cozzi Lepri, Cosmo Del Borgo, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 13, 2024
Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages eraAlessandra Vergori, Alessandro Cozzi Lepri, Marta Chiuchiarelli, et al.AIDS Research and Human Retroviruses|September 19, 2003
Neurocognitive performance and quality of life in patients with HIV infectionValerio Tozzi, Pietro Balestra, Simonetta Galgani, et al.Pageof 10